首頁 > 市場調查報告書 > 食物/飲料

生鮮食品

市場調查報告書

商品編碼

1747552

家禽藥物市場：依產品類型、依動物類型、按地區

Poultry Pharmaceuticals Market, By Product Type, By Animal Type, and By Region

出版日期: 2025年05月28日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

家禽藥物市場規模預計在 2025 年達到 87 億美元，預計到 2032 年將達到 157 億美元，2025 年至 2032 年的複合年成長率為 8.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	87億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	8.80%	2032年價值預測	157億美元

肉類、雞肉和雞蛋等家禽產品在全球範圍內被廣泛消費。對這些產品的需求正在上升，此外，對動物蛋白的需求增加預計是預測期內推動家禽藥品市場成長的主要因素。家禽數量的增加和禽病患病率的上升預計將推動通用疫苗的需求。由於人畜共通感染疾病的增加，對家禽疫苗的需求正在激增。家禽疫苗透過顯著增強免疫系統來產生對抗入侵生物的抗體，有助於預防某些疾病。家禽疫苗在控制和預防家禽疾病方面發揮重要作用。大多數家禽疫苗是為對抗病毒性疾病而開發的。這些疫苗以各種形式給藥，例如鼻內、口服、眼部、活疫苗、皮下和肌肉注射。

市場動態

主要市場參與者正致力於推出新型疫苗，以保護家禽免受馬立克氏症的侵害，預計這將在預測期內推動全球去活化家禽藥物市場的成長。例如，2020年，勃林格殷格翰（Boehringer Ingelheim）推出了VAXXITEK HVT+IBD+ND疫苗，該疫苗由德國一家以研發主導的企業集團組成，專注於創新醫療保健產品的發現、開發、生產和行銷。勃林格殷格翰在其基地生產VAXXITEK HVT+IBD+ND疫苗，該基地每年開發超過600億支家禽疫苗，供包括美國在內的60多個國家使用。

本研究的主要特點

本研究報告對全球家禽藥品市場進行了詳細分析，並以 2024 年為基準年，提供了 2025 年至 2032 年預測期內的市場規模和年複合成長率(CAGR)。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球家禽製藥市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球家禽製藥市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球家禽藥品市場所使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 8.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 15.7 Bn

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the increasing number of zoonotic cases. Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular.

Market Dynamics

Key market players are focusing on launch of new vaccine to protect poutry against Marek's Disease is expected to the global inactivated poultry pharmaceuticals market growth over the forecast period. For instance, in 2020, Boehringer Ingelheim, a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products in Germany, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Key features of the study:

This report provides an in-depth analysis of the global poultry pharmaceuticals market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global poultry pharmaceuticals market based on the following parameters- Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry pharmaceuticals market.

Market Segmentation

Global Poultry Pharmaceuticals Market, By Product Type:
- Drugs
- VETRIMOXIN
- Other Drug Products
- Vaccines
- INNOVAX
- NOBILIS
- Poulvac
- Other Vaccine Products
- Feed Additives
- VIGOSINE
- Amnovit
- Other Feed Additives
Global Poultry Pharmaceuticals Market, By Animal Type :
- Chicken
- Turkey
- Duck
- Goose
- Others
Global Poultry Pharmaceuticals Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Bayer AG
- Bimeda
- Ceva Sante Animale
- Elanco Animal Health (Eli Lilly and Company)
- Merck Animal Health
- Merial Animal Health (Sanofi)
- Virbac
- Boehringer Ingelheim
- Zoetis, Inc.
- Pacific GeneTech
- Avivagen Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Poultry Pharmaceuticals Market, By Product Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - VETRIMOXIN
  - Other Drug Products
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - INNOVAX
  - NOBILIS
  - Poulvac
  - Other Vaccine Products
Feed Additives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - VIGOSINE
  - ABnovit
  - Other Feed Additives

5. Global Poultry Pharmaceuticals Market, By Animal Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chicken
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Duck
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Goose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Poultry Pharmaceuticals Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
North America
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa
  - Rest of Africa

7. Company Profiles

Bayer AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bimeda
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health (Eli Lilly and Company)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck Animal Health
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merial Animal Health (Sanofi)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Virbac
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific GeneTech
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Avivagen Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

家禽腸道健康解決方案市場：2030 年預測

Ovo-性別鑑定技術市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按技術、最終用戶和地理位置

家禽市場 - 2023-2030

全球家禽維生素市場：按產品類型、按特性、按維生素類型：機會分析和產業預測（2023-2032）

家禽的全球市場報告 2023年

FAQ

家禽藥物市場：依產品類型、依動物類型、按地區